Ending AIDS Pricetag Starts at $6 Billion as Donors Pull Back Amid Slump
Published: Sep 12, 2011
Michel Kazatchkine and Eric Goosby may be able to halt the spread of HIV. They just need the money. The two men control the funds that buy drugs for most of the world’s AIDS patients. Studies in July provided the strongest evidence yet that medicines used since 1994 to treat HIV can almost eliminate the chance an infected person will pass the virus to a sex partner. Given to healthy people, the treatments can also protect against infection, offering the potential to end a pandemic that has killed 30 million people in 30 years.